Pruthi D, Khankin E, Blanton R, Aronovitz M, Burke S, Stillman I, McCurley A, Karumanchi SA, and Jaffe IZ. Exposure to Experimental Preeclampsia in Mice Enhances the Vascular Response to Injury Later in Life. Hypertension, 2015 (In Press).
Barrett Mueller K, Lu Q, Mohammad NN, Luu V, McCurley A, Williams GH, Adler GK, Karas RH, Jaffe IZ. Estrogen Receptor Inhibits Mineralocorticoid Receptor Transcriptional Regulatory Function. Endocrinology. 2014 Jul 22:en20141270.
Chen CW, Jaffe IZ, Karumanchi SA. Pre-eclampsia and cardiovascular disease. Cardiovasc Res. 2014 Mar 15;101(4):579-86. Pubmed Abstract
Dupont JJ, Hill MA, Bender SB, Jaisser F, Jaffe IZ. Aldosterone and Vascular Mineralocorticoid Receptors: Regulators of Ion Channels Beyond the Kidney. Hypertension. 2013 Dec 30. [Epub ahead of print] No abstract available. [PubMed - as supplied by publisher].
Pruthi D, McCurley A, Aronovitz M, Galayda C, Karumanchi SA, Jaffe IZ. Aldosterone Promotes Vascular Remodeling by Direct Effects on Smooth Muscle Cell Mineralocorticoid Receptors. Arterioscler Thromb Vasc Biol. 2013 Dec 5. [Epub ahead of print].
McGraw AP, Bagley J, Chen WS, Galayda C, Nickerson H, Armani A, Caprio M, Carmeliet P, Jaffe IZ.Aldosterone increases early atherosclerosis and promotes plaque inflammation through a placental growth factor-dependent mechanism. J Am Heart Assoc. 2013 Feb 22;2(1):e000018. doi: 10.1161/JAHA.112.000018.
Preston IR, Sagliani KD, Warburton RR, Hill NS, Fanburg BL, Jaffe IZ. Mineralocorticoid receptor antagonism attenuates experimental pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2013 May 15;304(10):L678-88. doi: 10.1152/ajplung.00300.2012. Epub 2013 Mar 1.
Ehsan A, McGraw AP, Aronovitz MJ, Galayda C, Conte MS, Karas RH, Jaffe IZ. Mineralocorticoid receptor antagonism inhibits vein graft remodeling in mice. J Thorac Cardiovasc Surg. 2013 Jun;145(6):1642-9, 1649.e1. doi: 10.1016/j.jtcvs.2012.08.007. Epub 2012 Sep 13.
McCurley A, Pires PW, Bender SB, Aronovitz M, Zhao MJ, Metzger D, Chambon P, Hill MA, Dorrance AM, Mendelsohn ME, Jaffe IZ. Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors. Nat Med. 2012 Sep;18(9):1429-33.
McCurley A, Jaffe IZ. Mineralocorticoid receptors in vascular function and disease. Mol Cell Endocrinol. 2012 Mar 24;350(2):256-65. doi: 10.1016/j.mce.2011.06.014. Epub 2011 Jun 24. Review.
Newfell BG, Iyer LK, Mohammad NN, McGraw AP, Ehsan A, Rosano G, Huang PL, Mendelsohn ME, Jaffe IZ.Aldosterone regulates vascular gene transcription via oxidative stress-dependent and -independent pathways. Arterioscler Thromb Vasc Biol. 2011 Aug;31(8):1871-80. doi: 10.1161/ATVBAHA.111.229070. Epub 2011 May 26
Jaffe IZ, Newfell BG, Aronovitz M, Mohammad NN, McGraw AP, Perreault RE, Carmeliet P, Ehsan A, and Mendelsohn ME. Placental Growth Factor Mediates Aldosterone-Dependent Vascular Injury. Journal of Clinical Investigation 2010; 120(11):3891-3900.
Caprio M, Newfell BG, la Sala A, Baur W, Fabbri A, Rosano G, Mendelsohn ME, Jaffe IZ. Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion. Circulation Research 2008;102(11):1359-1367.
Jaffe IZ, Mendelsohn ME. Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells. Circulation Research 2005;96(6):643-650.
Iris Jaffe, MD, PhD is the Elisa Kent Mendelsohn Professor of Molecular Cardiology and Executive Director of the Molecular Cardiology Research Institute (MCRI) at Tufts Medical Center, in Boston, MA where she is also an attending Cardiologist. Dr. Jaffe received her BA in Biochemistry, PhD in Molecular Biology, and MD degrees all at the University of Pennsylvania in Philadelphia. She completed her Internal Medicine Residency training at Massachusetts General Hospital, clinical Cardiology fellowship at Brigham and Women’s Hospital and Vascular Biology Research Fellowship in the MCRI at Tufts Medical Center, all in Boston, MA. Iris joined the faculty at Tufts Medical Center in 2005 and was promoted to Professor of Medicine at Tufts University School of Medicine in 2017.
Dr. Jaffe’s research combines her background in molecular and vascular biology with her interest as a clinical Cardiologist to explore molecular mechanisms that contribute to common cardiovascular diseases with a goal of identifying novel treatments. Her lab has specifically focused on the role of the aldosterone-responsive mineralocorticoid receptor (MR) in blood vessels and demonstrated a direct contribution to hypertension, atherosclerosis, vascular remodeling, vein graft failure, and pulmonary hypertension.
Dr. Jaffe is the recipient of numerous grants, awards and honors for her research discoveries, including the Established Investigator Award from the American Heart Association and she is an elected member of the American Society of Clinical Investigation (ASCI). Iris Jaffe has served as Associate Editor for Clinical Science and on the Editorial Boards of Endocrinology and Hypertension. She is a standing member of the NIH Vascular Cell and Molecular Biology (VCMB) Study Section which she currently chairs.
Molecular Cardiology Research Institute
Tufts Medical Center
800 Washington Street, Box #7703
Boston, MA 02111